News

New tool guides families on RSV immunization
Researchers from the Wesfarmers Center of Vaccines and Infectious Diseases, based at The Kids Research Institute Australia, ...
Healio12d
RSV may elevate risk for stroke, heart failure hospitalization
Acute respiratory syncytial virus was associated with elevated incidence of cardiovascular events among older adults, ...
Medscape1d
ACIP Backs RSV Shot for Some 50- to 59-Year-Olds, New Meningitis Vaccine
At its first meeting under the new administration, the US Centers for Disease Control and Prevention’s (CDC) Advisory ...
PharmExec3d
ArkBio’s Ziresovir Demonstrates Clinical Efficacy in Hospitalized Infants with Respiratory Syncytial Virus
Ziresovir is the first antiviral to demonstrate significant clinical efficacy and long-term respiratory benefits in ...
EurekAlert!9d
Common respiratory condition nearly triples the risk of death in adults, new study finds
A major study presented today at ESCMID Global 2025 has revealed that adults with respiratory syncytial virus-associated acute respiratory infection (RSV-ARI) face a 2.7-fold higher risk of death ...
Vietnam Investment Review4d
The Lancet Publishes Ziresovir Phase III RSV Trial in Infants Under 6 Months
Ziresovir's Phase III results mark a significant milestone, representing the first clinical validation of an antiviral's ...
The Manila Times4d
The Lancet Child & Adolescent Health Publishes Phase III Trial and 24-Month Follow-Up Results of Ziresovir for RSV in Infants Under 6 Months
The Lancet Child & Adolescent Health, a leading international journal in pediatric and adolescent medicine, has published the ...